GlassScriptPhysician profile
Jeffrey A Mann
NPI 1114964400
$3,844.16
in general payments reported to CMS, 2019-2025
10 companies · $805 in 2025
The $805 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.23 · 2020: $286 · 2021: $725 · 2022: $182 · 2023: $1,627 · 2024: $165 · 2025: $805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,580 · Food and Beverage: $1,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,579.99 |
| Food and Beverage | $1,017.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $1,115.68 | 2019-2022 | |
| Evolution Surgical, INC | $1,058.61 | 2023-2025 | |
| Stryker Corporation | $856.58 | 2023-2025 | Mako, Inbone, Infinity |
| Arthrex, INC. | $397.40 | 2023 | |
| Collegium Pharmaceutical, INC. | $161.28 | 2022-2025 | Belbuca |
| Depuy Synthes Sales INC. | $140.63 | 2019-2024 | N/A, Motoband Cp |
| Globus Medical, INC. | $47.96 | 2021 | |
| Paragon 28, INC. | $31.94 | 2023 | Monkey Rings |
| Ferring Pharmaceuticals INC. | $18.81 | 2020 | |
| Bioventus LLC | $15.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.